Cyclica
Biotechnology ResearchCanada51-200 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Acquisition by Recursion Cyclica has been acquired by Recursion, indicating a potential partnership or collaboration opportunity with the merged entity.
Technology Stack Utilization of tech tools like Microsoft Clarity, Amplitude, and Google Tag Manager suggests a need for software solutions that can integrate with these platforms for enhanced efficiency.
Revenue and Funding With revenue between $10M - $50M and $1.8M in funding, Cyclica presents a target market that values solutions offering high ROI and cost-effectiveness.
Similar Company Comparison Comparing against similar biotech research companies like Atomwise, Relay Therapeutics, and Exscientia allows for tailored sales pitches based on industry benchmarks and competitive analysis.
Market Trend Alignment Synchronizing sales strategies with market trends highlighted in news articles about ETF performances and Wall Street activities can position offerings as timely solutions to current industry shifts and demands.
Cyclica uses 8 technology products and services including Microsoft Clarity, Amplitude, Profitwell, and more. Explore Cyclica's tech stack below.
Cyclica Email Formats | Percentage |
First.Last@cyclicarx.com | 100% |
First@beacons.ai | 83% |
Last@beacons.ai | 14% |
FirstL@beacons.ai | 2% |
FLast@beacons.ai | 1% |
Biotechnology ResearchCanada51-200 Employees
Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter.
Cyclica has raised a total of $1.8M of funding over 8 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $1.8M.
Cyclica's revenue is in the range of $10M$50M
Cyclica has raised a total of $1.8M of funding over 8 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $1.8M.
Cyclica's revenue is in the range of $10M$50M